Lung Cancer
News
Can aspirin prolong survival in patients with NSCLC?
“Any potential benefit of aspirin in lung cancer patients needs to be balanced against known adverse events associated with prolonged aspirin use...
Latest News
Three drugs go head-to-head in advanced lung cancer study
This is the first-known analysis that compares atezolizumab, nivolumab, and docetaxel in patients outside of clinical trials. Atezolizumab and...
Latest News
Common lung cancer screening tool superior to alternatives
CT scans are increasingly used for lung cancer screening, so accuracy is essential in devising an appropriate treatment plan for patients.
News
One-quarter of lung cancer patients alive at 5 years
“If you look back, the 5-year survival rate has been very slowly eking up at about 1% over the years.”
News
Substantial declines in mortality for most cancers
“The cancer mortality rate has reduced considerably since 1971 overall and for most cancer sites because of improvements in prevention, early...
Latest News
SBRT on oligoprogressive lesions: Benefit in lung cancer
Stereotactic body radiation therapy proves to be beneficial for non–small cell lung cancer, but there was no benefit for breast cancer patients....
News
Severe COVID two times higher for cancer patients
News
Antibiotic and glucocorticoid use before cancer therapy could have detrimental effect on outcomes
Observational study finds that antibiotics and glucocorticoids at 10 mg daily when given within 1 month before or after immune checkpoint...
News
Lung cancer screening rates in U.S. nowhere near goal
Lung cancer screening is effective in reducing mortality, particularly when patients adhere to follow-up recommendations, but too few patients in...
Latest News
Pfizer offers refund if drug ‘doesn’t work’
Although Pfizer claims that its pilot program is a first in the industry, there have been others that are similar.